Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety.
Christenhusz A, den Dekker BM, van Dalen T, Jongen L, van der Schaaf MC, Alic L, Ten Haken B, Pijnappel RM, Dassen AE. Christenhusz A, et al. Among authors: jongen l. Breast Cancer Res Treat. 2023 Aug;201(1):67-75. doi: 10.1007/s10549-023-07006-x. Epub 2023 Jun 15. Breast Cancer Res Treat. 2023. PMID: 37322358 Free PMC article.
Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study.
Ragusi MAA, van der Velden BHM, Meeuwis C, Tetteroo E, Coerkamp EG, van Nijnatten TJA, Jansen FH, Wolters-van der Ben EJM, Jongen L, van Raamt F, Dorrius MD, Verloop J, Viergever MA, Pijnappel RM, Elias SG, Gilhuijs KGA. Ragusi MAA, et al. Among authors: jongen l. Radiology. 2023 May;307(4):e221922. doi: 10.1148/radiol.221922. Epub 2023 Mar 28. Radiology. 2023. PMID: 36975820
A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and rationale of the RFID Localizer 1 Trial.
den Dekker BM, Christenhusz A, van Dalen T, Jongen LM, van der Schaaf MC, Dassen AE, Pijnappel RM. den Dekker BM, et al. Among authors: jongen lm. BMC Cancer. 2022 Mar 22;22(1):305. doi: 10.1186/s12885-022-09394-7. BMC Cancer. 2022. PMID: 35317766 Free PMC article.
Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer.
Slembrouck L, Vanden Bempt I, Wildiers H, Smeets A, Van Rompuy AS, Van Ongeval C, Jongen L, Weltens C, Punie K, Hoste G, Van Nieuwenhuysen E, Han S, Nevelsteen I, Neven P, Floris G. Slembrouck L, et al. Among authors: jongen l. Mod Pathol. 2021 Jul;34(7):1297-1309. doi: 10.1038/s41379-021-00743-8. Epub 2021 Feb 8. Mod Pathol. 2021. PMID: 33558657 Free article.
Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Floris G, Richard F, Hamy AS, Jongen L, Wildiers H, Ardui J, Punie K, Smeets A, Berteloot P, Vergote I, De Croze D, Meseure D, Salomon A, Laé M, Reyal F, Biganzoli E, Neven P, Desmedt C. Floris G, et al. Among authors: jongen l. J Natl Cancer Inst. 2021 Feb 1;113(2):146-153. doi: 10.1093/jnci/djaa090. J Natl Cancer Inst. 2021. PMID: 33152071 Free PMC article.
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.
Slembrouck L, Darrigues L, Laurent C, Mittempergher L, Delahaye LJ, Vanden Bempt I, Vander Borght S, Vliegen L, Sintubin P, Raynal V, Bohec M, Reyes C, Rapinat A, Helsmoortel C, Jongen L, Hoste G, Neven P, Wildiers H, Smeets A, Nevelsteen I, Punie K, Van Nieuwenhuysen E, Han S, Vincent Salomon A, Laas Faron E, Cynober T, Gentien D, Baulande S, Snel MH, Witteveen AT, Neijenhuis S, Glas AM, Reyal F, Floris G. Slembrouck L, et al. Among authors: jongen l. Transl Oncol. 2019 Dec;12(12):1557-1565. doi: 10.1016/j.tranon.2019.08.008. Epub 2019 Sep 9. Transl Oncol. 2019. PMID: 31513983 Free PMC article.
Silent Intracerebral Hemorrhage in Patients Randomized to Stenting or Endarterectomy for Symptomatic Carotid Stenosis.
Müller MD, Jongen LM, Altinbas A, Blackham KA, Nederkoorn PJ, Macdonald S, Jäger R, Wolff T, Lyrer PA, Kappelle LJ, Wetzel SG, Richards T, Hendrikse J, de Borst GJ, van der Worp HB, Engelter ST, Werring DJ, Brown MM, Bonati LH; ICSS-MRI Study Investigators. Müller MD, et al. Among authors: jongen lm. J Stroke. 2019 Jan;21(1):116-119. doi: 10.5853/jos.2018.02838. Epub 2019 Jan 31. J Stroke. 2019. PMID: 30732448 Free PMC article. No abstract available.
Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.
Sanchez-Spitman A, Dezentjé V, Swen J, Moes DJAR, Böhringer S, Batman E, van Druten E, Smorenburg C, van Bochove A, Zeillemaker A, Jongen L, Los M, Neven P, Gelderblom H, Guchelaar HJ. Sanchez-Spitman A, et al. Among authors: jongen l. J Clin Oncol. 2019 Mar 10;37(8):636-646. doi: 10.1200/JCO.18.00307. Epub 2019 Jan 24. J Clin Oncol. 2019. PMID: 30676859
Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer.
Hoste G, Slembrouck L, Jongen L, Punie K, Matton T, Vander Borght S, Vanden Bempt I, Menten J, Wildiers H, Floris G, Arteaga C, Neven P. Hoste G, et al. Among authors: jongen l. Clin Drug Investig. 2019 Jan;39(1):113. doi: 10.1007/s40261-019-00748-x. Clin Drug Investig. 2019. PMID: 30637612
38 results